Erectile dysfunction (ED) may be an early sign or symptom of cardiovascular disease (CVD). We examined the relation of traditional and emerging risk factors for CVD to the severity of penile vascular disease in men with ED and without clinical coronary artery disease (CAD). In total, 137 men with ED were evaluated for penile vascular disease severity by penile Doppler ultrasound. These men were divided into the following groups based on ultrasound results: normal, cavernous venous occlusive disease, mild arterial insufficiency, and severe arterial insufficiency. Traditional (fasting lipid panel, fasting glucose, age, BMI, smoking, Framingham coronary artery disease risk score) and emerging (C-reactive protein, Lp(a), homocysteine) risk factors for CVD were correlated to severity of penile vascular disease in men with ED and without clinical CAD. Using univariate analysis, penile Doppler groups showed significant positive correlation to CRP (r ¼ 0.21; Po0.05) and age (r ¼ 0.30; Po0.01). For CRP, this correlation remained significant even when adjusted for age (Po0.05). Men displaying evidence of penile arterial disease (mild and severe arterial insufficiency) were characterized by elevated CRP levels (0.17 mg/dl) compared to men with no evidence of arterial abnormalities in the penis (0.04 mg/dl). CRP levels correlate significantly with increasing severity of penile vascular disease as measured by penile Doppler.
Background
Erectile dysfunction (ED) has traditionally been considered a disease that develops in patients with advanced systemic cardiovascular disease (CVD). However, evidence is accumulating that ED may be an early manifestation of systemic atherosclerosis and may precede the development of clinically significant vascular disease in other organs. In one study, 64% of men who presented with myocardial infarction (MI) reported ED before the onset of heart problems. 1 Similarly, 57% of men undergoing coronary bypass surgery reported ED prior to the operation. 2 Recent clinical research studies show that the presence or severity of penile vascular disease correlates with some cardiovascular risk factors. Chung et al 3 found that the vasodilatory capacity of the penile vascular bed in patients with ED showed an inverse relation to the number of CVD risk factors, including the presence of diabetes. Other investigators have reported a higher incidence of abnormal penile blood flow when the patient history includes risk factors such as previous MI, hypertension, or cigarette smoking.
2,4,5 Kawanishi et al 6 showed that men with ED and an abnormal penile Doppler ultrasound exam are at increased risk for ischemic heart disease. 6 To date, there have been few studies assessing the relation between the severity of penile vascular disease and traditional CVD risk factors. Furthermore, little data exist concerning the relation between emerging markers for CVD risk (C-reactive protein (CRP), Lp(a), homocysteine) and penile vascular disease severity. In particular, highsensitivity CRP, a marker for inflammation and independent predictor for developing CVD, 7 may be a potential mechanism linking ED and atherosclerosis because of its role as an atherogenic mediator in the vasculature. Therefore, the purpose of this study was to examine the relation between penile vascular disease severity and markers of CVD risk.
Methods

Patient population
Patients were recruited from a urology clinic specializing in male sexual dysfunction. Inclusion criteria included history of organic ED for 43 months and an age range between 20 and 64 y old.
Patients were excluded for known clinical coronary or peripheral arterial disease, history of neurological disease, pelvic trauma, major psychiatric disorder, or prostate cancer. All patients underwent a thorough history and physical examination. Informed consent was obtained from all the participants. The study was approved by a local Institutional Review Board.
Penile Doppler studies
Penile Doppler studies were performed using the Knoll/Midus ultrasonic velocitometry system (Urometrics, St Paul). This system incorporates a penile ultrasonic velocitometer that uses two moveable fixed angle 8 MHz transducers to measure cavernosal artery velocity as an indicator of penile blood flow. Measurements included peak-systolic velocity (PSV), end-diastolic velocity (EDV), and resistance index (RI ¼ PSVÀEDV/PSV). Previous measurements using this system have correlated well with duplex ultrasonography. 8 One investigator (KLB) performed all of the Doppler testing. All subjects received 10-20 mg of intracavernosal prostaglandin E-1 (Caverject, Pharmacia, NJ, USA) and measurements were performed at 5 and 15 min postinjection to determine the PSV, EDV, and RI. Subjects were initially injected with 10 mg of PGE-1 and graded on a rigidity scale of 1-5 (1 ¼ poor response, 2 ¼ tumescence without rigidity, 3 ¼ partial rigidity, 4 ¼ good rigidity, 5 ¼ priapism). Any subject scoring 1/5 or 2/5 on the rigidity scale (ie a poor response to PGE-1 injection) was injected with another 10 mg of PGE-1 to assure adequate smooth muscle relaxation and Doppler measurements were repeated. Penile Doppler classifications were as follows: normal for PSV Z35 cm/s and RI Z0.9; cavernous venous occlusive disease (CVOD) for PSV Z35 cm/s and RI o0.9; mild arterial insufficiency (MAI) for PSV between 25 and 35 cm/s; and severe arterial insufficiency (SAI) for bilateral PSV o25 cm/s. Based on the above penile Doppler classification, normal, CVOD, MAI, and SAI represented a scale of increasing severity with respect to penile vascular disease. Determination of severity classification based on Doppler values was derived from previously published criteria.
9,10
Questionnaires Subjects completed a cardiac risk questionnaire based on items chosen from the Framingham criteria to calculate coronary artery disease (CAD) risk score. 11 In addition, the five-item abbreviated version of the International Index of Erectile Function (IIEF-5) was used to assess erectile function. 12 Each patient also completed a detailed questionnaire as part of the initial visit to assess medical and sexual history.
Laboratory tests
Fasting blood analyses included: lipid panel (total, HDL, and LDL-cholesterol, and triglycerides), glucose, total homocysteine (tHcy), Lp(a), and high sensitivity CRP. All blood samples were drawn into serum EDTA-containing tubes with 3.2% buffered citrate and separated within one half hour. Serum and plasma aliquots were frozen immediately at À701C until analyzed. Total and HDL-cholesterol, triglyceride, and glucose were measured in serum by colorimetric reflectance spectrophomotometry using the Vitros analyzer (Johnson & Johnson Clinical Diagnostics, Inc., Rochester, NY, USA). For analysis of HDL-cholesterol, the non-HDL cholesterol was first precipitated with magnetic 50 000 MW dextran sulfate and magnesium chloride. LDL-cholesterol was calculated in serum containing a triglyceride value o400 mg/dl using the formula of Friedewald et al. 13 Fasting tHcy was measured in EDTA plasma by a fluorescence polarization immunoassay (IMx homocysteine Assay, Axis Biochemicals ASA, Oslo, Norway) using the IMx Analyzer (Abbott Diagnostics, Abbott Park, II, USA). Lp(a) was quantitated in serum by an automated immunoprecipitin method (SPQ Antibody Reagent Sett for Lp(a), DiaSorin Inc., Stillwater, MN, USA) using the Roche Cobas FARA centrifugal analyzer (Boehringer Mannheim Diagnostics). High-sensitivity CRP was determined on the Roche Cobas Mira centrifugal analyzer (Boehringer Mannheim Diagnostics) using a latex particle enhanced immunoturbidimetric assay (K-ASSAY s CRP (2), Kamiya Biomedical Company, Seattle, WA, USA). 
Results
Patient characteristics
In total, 137 patients participated in this study over a 9-month period. Doppler studies placed patients into the following categories: (1) normal penile Doppler (n ¼ 6, 4.4%); (2) CVOD (n ¼ 15, 10.9%); (3) MAI (n ¼ 76, 55.5%); and (4) SAI (n ¼ 40, 29.2%). Table 1 shows the demographics of all participants. At the time of the study, 4% were diagnosed as having type II diabetes mellitus and 12% were diagnosed as having hypertension (4160/90). Figure 1 plots the mean PSV, EDV, and RI for the four groups of patients. Mean PSV, by definition, separated the three groups of patients with vascular ED. EDV was highest in the CVOD group as expected. Mean RI was reduced in the three groups with vascular ED. In the CVOD group, RI was reduced because of an elevated EDV with a normal PSV, whereas in the two groups with arterial disease, RI was reduced as a result of a low PSV with a relatively normal EDV. Figure 2 shows that age was significantly associated with severity of penile vascular disease (r ¼ 0.30, Po0.01).
Smoking status was divided into two categories: Figure 1 Measurements included PSV, EDV, and (RI ¼ PSV ÀEDV/PSV). Penile Doppler classifications were: normal for PSV Z35 cm/s and RI Z0.9; CVOD for PSV Z35 cm/s and RI o0.9; MAI for PSV between 25 and 35 cm/s; and SAI for bilateral PSV o25 cm/s. PSV, by definition, separated the three groups of patients with vascular ED. EDV was highest in the CVOD group as expected. Mean RI was reduced in the three groups with vascular ED. In the CVOD group, RI was reduced because of an elevated EDV with a normal PSV, whereas in the two groups with arterial disease, RI was reduced as a result of a low PSV with a relatively normal EDV.
Penile vascular disease in men with ED AJ Bank et al (1) current smokers (47%) and (2) those who never smoked (20%) plus those who quit more than 5 y ago (33%). No significant association was found between most of the traditional cardiovascular risk factors (BMI, SBP, DBP, smoking status) and penile vascular disease severity. CAD risk score trended towards significance, but this trend disappeared when age was omitted from the score (P ¼ 0.53). Table 2 shows the laboratory results of all the participants. No significant association was found between penile vascular disease severity and triglycerides, HDL, LDL, or total cholesterol. In addition, there was no association between fasting glucose, homocysteine, or Lp(a). CRP was significantly associated with progressively increasing penile vascular disease severity (r ¼ 0.21 and Po0.05). This association remained significant after adjusting for age (Po0.05) (Figure 3) . CRP, triglyceride, and glucose values in this cohort were skewed, so statistics were repeated using logarithmic transformations of these variables. Log (triglycerides) and log(glucose) were still not significantly associated with increasing penile vascular disease severity.
Laboratory markers of cardiovascular risk
Log(CRP) remained independently associated with increasing penile vascular disease severity.
Discussion
This study is the first to demonstrate that the severity of penile vascular disease, as measured by penile Doppler ultrasound, is associated with progressively increasing levels of CRP in men with ED. Inflammatory markers have been shown in many studies to predict increased mortality in both high-risk groups and apparently healthy individuals. 7 It is unknown if these inflammatory markers are elevated as a result of vascular damage or play a direct role in the pathogenesis of atherosclerosis. CRP has emerged as one of the most prominent inflammatory markers for CVD risk. Our study population was limited to men with ED and no known clinical CAD or peripheral arterial disease, neurological, traumatic, or psychiatric disorders in an effort to examine ED as an early indicator of systemic atherosclerosis and CVD.
We found that many traditional risk factors for heart disease were not associated with increasing severity of ED. These risk factors are either markers for, or causative agents in, the development of atherosclerosis. It was surprising to note that traditional risk factors for heart disease such as BMI, lipids, blood pressure, and glucose were all within normal limits. Even the levels of emerging risk factors such as tHcy, Lp(a), and CRP were all within the normal limits. Still, we found a signifi- Penile vascular disease in men with ED AJ Bank et al cant independent correlation between serum CRP levels and increasing severity of penile vascular disease. Recent evidence suggests that CRP directly affects the vascular endothelium by upregulating chemokines and adhesion molecules, and inducing monocyte recruitment. 15, 16 Our findings show a correlation between CRP levels and penile vascular disease severity in men with ED. In vitro experiments confirm that elevated CRP results in a decrease of eNOS expression and bioactivity. 17 In vivo experiments report a blunted blood flow response to acetylcholine in individuals with progressively increasing serum CRP levels. 16 While CRP levels in these studies were fivefold higher, other studies with CRP levels as low as those found in our group of ED patients with MAI or SAI demonstrated an association between CRP and decreased endothelial function and increased vascular remodeling. 18 In our study, it is possible that CRP may be one mechanism contributing to vascular dysfunction in patients with ED. Alternatively, ED may be the first sign of systemic vascular disease, and CRP is elevated in response. The penis may be a more sensitive vascular bed to systemic disease because of the small diameter of the cavernosal arteries and the high content of smooth muscle, on a per gram tissue basis, compared to other organs. Therefore, ED can be the result of any number of structural or functional abnormalities in the vascular bed. For instance, ED may result from occlusion of the cavernosal arteries by atherosclerosis (structural vascular ED), impairment of endothelial-dependent and/or -independent smooth muscle relaxation (functional vascular ED), or a combination of these two factors.
Our findings of an association between CRP and ED was unique among the traditional and emerging risk factors assessed. We found no association between penile vascular disease and fasting lipid panel values (total, LDL, HDL-cholesterol, and triglycerides), tHcy, Lp(a), or fasting glucose. Among traditional risk factors, only age was significantly associated with penile arterial disease severity. Given that most of the cardiovascular risk factors in our study group were normal, these data support the concept that in a relatively healthy population an early sign of systemic vascular disease may be the abnormal penile Doppler flow. Another study confirmed our results by showing penile Doppler score to be a more reliable test for the presence of ischemic heart disease than many traditional cardiovascular risk factors. 6 In that study, the mean PSV of the patients without ischemic heart disease was 34.6 vs 22.0 cm/s in those with ischemic heart disease. The sensitivity of PSV against ischemic heart disease was 92.9% and specificity was 59.1%. Together, these two studies suggest that ED may have a clinical role as a risk stratification tool for CVD.
One limitation of this study is the relatively small number of subjects in the normal penile Doppler group. One reason for this was the inclusion criteria of ED and the relatively small percentage of these men that have normal penile Doppler exams. If we grouped together those without arterial disease (normal and CVOD, n ¼ 21) and compared the CRP levels to the MAI and SAI groups, the same conclusion would be reached. Another limitation of this study is the relatively large number of patients who smoked, approximately 50%. Smoking has been associated with elevated CRP. 19, 20 However, smokers were evenly distributed among penile Doppler groups as shown in Table 1 . All of the patients diagnosed with diabetes mellitus (n ¼ 5) were in the SAI group. However, there were none in the MAI group and this group had CRP levels as high as the SAI group.
In conclusion, this study demonstrates a significant association between CRP and penile arterial disease severity as assessed by penile Doppler ultrasound studies. Although these data do not demonstrate a causal relation between CVD risk factors and ED severity, it raises the possibility that even modest increases in markers of vascular disease within the normal range of values may be associated with the development or progression of vascular ED. It also provides further support to the hypothesis that ED may precede the clinical diagnosis of CVD in other vascular beds.
